Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PRVB | Common Stock | Other | $0 | -3M | -25.25% | $0.00 | 8.88M | Mar 31, 2023 | Direct | F1, F2 |
transaction | PRVB | Common Stock | Gift | $0 | -219K | -33.87% | $0.00 | 427K | Apr 4, 2023 | Direct | F3, F4 |
Id | Content |
---|---|
F1 | Sessa Capital (Master), L.P. distributed these shares to its partners on a pro rata basis, for no consideration. |
F2 | These securities of Provention Bio, Inc. are beneficially owned by (i) Sessa Capital (Master), L.P. (the "Fund"), as a result of direct beneficial ownership of the shares, (ii) Sessa Capital GP, LLC, indirectly as a result of being the sole general partner of the Fund, (iii) Sessa Capital IM, L.P. indirectly as a result of being the investment adviser for the Fund, (iv) Sessa Capital IM GP, LLC, indirectly as a result of being the sole general partner of Sessa Capital IM, L.P., and (v) John Petry, indirectly as a result of being the manager of Sessa Capital GP, LLC and Sessa Capital IM GP, LLC. Each of the Reporting Persons and Mr. Petry disclaim beneficial ownership of any securities reported by any person except to the extent of their pecuniary interest therein. |
F3 | These shares of Common Stock were donated by John Petry to Fidelity Investments Charitable Gift Fund, a donor advised fund. |
F4 | Held directly by Mr. Petry. |